Clonal hematopoiesis of indeterminate potential (CHIP): Outcomes and adverse events in patients with solid tumors

被引：0
|
作者：
Krishnan, Tharani
Vasconcelos, Joao Paulo Solar
Titmuss, Emma
Topham, James T.
Vanner, Robert
Schaeffer, David F.
Karsan, Aly
Lim, Howard J.
Ho, Cheryl
Brown, Carl J.
Gill, Sharlene
Kennecke, Hagen Fritz
Jonker, Derek J.
Chen, Eric Xueyu
Renouf, Daniel John
O'Callaghan, Christopher J.
Loree, Jonathan M.
机构：
[1] Univ British Columbia, BC Canc Vancouver, Vancouver, BC, Canada
[2] BC Canc Vancouver, Vancouver, BC, Canada
[3] Pancreas Ctr BC, Vancouver, BC, Canada
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Vancouver Gen Hosp, Dept Pathol Lab Med, Vancouver, BC, Canada
[6] British Columbia Canc Res Ctr, Vancouver, BC, Canada
[7] Providence Hlth St Pauls Hosp, Vancouver, BC, Canada
[8] Oregon Hlth & Sci Univ, Portland, OR USA
[9] Ottawa Hosp, Canc Ctr, Ottawa, ON, Canada
[10] Univ Hlth Network, Toronto, ON, Canada
[11] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3521
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IS ASSOCIATED WITH FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WITH EARLY VASCULAR AGING
    Akhiyat, Nadia
    Lasho, Terra
    Ganji, Morsaleh
    Toya, Takumi
    Shi, Chang-Xin
    Chen, Xianfeng
    Corban, Michel
    Braggio, Esteban
    Ahmad, Ali
    Keith, Stewart
    Lerman, Lilach O.
    Mrinal, Patnaik.
    Lerman, Amir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1760 - 1760
  • [32] Extramedullary findings of clonal hematopoiesis of indeterminate potential (CHIP) in an otherwise healthy patient
    Ramdohr, F.
    Monecke, A.
    Zehrfeld, T.
    Doehring, C.
    Poenisch, W.
    Schwind, S.
    Jentzsch, M.
    Platzbecker, U.
    Vucinic, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 264 - 264
  • [33] Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
    Nagendra Boopathy Senguttuvan
    Vinodhini Subramanian
    Vettriselvi Venkatesan
    T. R. Muralidharan
    Kavitha Sankaranarayanan
    Journal of Genetic Engineering and Biotechnology, 19
  • [34] Managing Clonal Hematopoiesis in Patients With Solid Tumors
    Bolton, Kelly L.
    Gillis, Nancy K.
    Coombs, Catherine C.
    Takahashi, Koichi
    Zehir, Ahmet
    Bejar, Rafael
    Garcia-Manero, Guillermo
    Futreal, Andrew
    Jensen, Brian C.
    Diaz, Luis A., Jr.
    Gupta, Dipti
    Mantha, Simon
    Klimek, Virginia
    Papaemmanuil, Elli
    Levine, Ross
    Padron, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (01) : 7 - +
  • [35] Clonal Hematopoiesis of Indeterminate Potential in Korean Patients with Cognitive Impairment
    Kim, H.
    Youn, Y.
    Yun, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S14 - S15
  • [36] Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)
    Craven, Kelly E.
    Ewalt, Mark D.
    CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 565 - 576
  • [37] Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients
    Perez Gonzalez, Ana
    Pellin Jou, Claudia
    Palomo, Laura
    Navarro Garces, Victor
    Calvete, Oriol
    Zamora, Esther
    Saoudi Gonzalez, Nadia
    Farinas-Madrid, Lorena
    David Assaf, Juan
    Eugenia Rivero, Maria
    Molero Yordi, Antonieta
    Salamero, Olga
    Jerez, Andres
    Garrido Paniagua, Sara
    Sola, Maria
    Novoa Jauregui, Sandra
    Jimenez, Moraima
    Beas, Francisco
    Sole, Francesc
    Diez-Campelo, Maria
    Alfonso Pierola, Ana
    Bosch, Francesc
    Montoro, Julia
    Valcarcel Ferreiras, David
    BLOOD, 2023, 142
  • [38] Identifying gut microbial determinants of clonal hematopoiesis of indeterminate potential (CHIP) in immunotherapy treated melanoma patients
    Fallon, Eleanor A.
    Urrutia, Samuel
    Ayabe, Reed
    Chelvanambi, Manoj
    Damania, Ashish
    Johnson, Sarah
    Tanaka, Tomoyuki
    Li, Zongrui
    Seo, Yongwoo David
    Cass, Samuel
    Wong, Matthew C.
    Ajami, Nadim
    Wargo, Jennifer
    Takahashi, Koichi
    CANCER RESEARCH, 2024, 84 (06)
  • [39] PREVALENCE, DYNAMICS AND CLINICAL SIGNIFICANCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN NEWLY DIAGNOSED CANCER PATIENTS
    Perez Gonzalez, A.
    Peralta-Garzon, S.
    Palomo, L.
    Navarro, V.
    Molero Yordi, A.
    Tazon-Vega, B.
    Calvete, O.
    Salamero, O.
    Saumell, S.
    Rivero, E.
    Zamora, E.
    Saoudi, N.
    Farinas, L.
    Torres-Esquius, S.
    Novoa, S.
    Garrido, S.
    Sola, M.
    Campelo, M.
    Alfonso, A.
    Montoro, M. J.
    Valcarcel, D.
    LEUKEMIA RESEARCH, 2023, 128
  • [40] Clonal Hematopoiesis of Indeterminate Potential (CHIP) is Associated with Shorter Overall Survival (OS) in Patients with Multiple Myeloma
    Rexha, Farah
    Han, Ryan
    Gustine, Joshua
    Nakamoto-Matsubara, Rie
    Shome, Rajib
    Panaroni, Cristina
    Ochi, Kiyosumi
    Nardi, Valentina
    Branagan, Andrew
    Cirstea, Diana
    Yee, Andrew
    Raje, Noopur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S177 - S178
12345